Symptomatic BK virus reactivation following fludarabine, cyclophosphamide and rituximab chemotherapy for chronic lymphocytic leukemia/small lymphocytic lymphoma

By Appleby Niamh   Dillon Anna   Arrigan Martin   Fennell Jerome   Crowley Brendan   Hayden Patrick J.   Enright Helen  

Leukemia and Lymphoma, Vol. 55, Iss. 5, 2014-05 ,pp. : 1181-1183

Informa Healthcare

Access to resources Recommend Favorite

Spotlight on Rituximab in Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia

By Plosker G.L.   Figgitt D.P.  

American Journal of Cancer, Vol. 2, Iss. 4, 2003-01 ,pp. : 283-289

Adis International

Access to resources Recommend Favorite

Acute lymphocytic leukemia mimicking spondyloarthritis in an adolescent: A case report and review of the literature

By Xu Danyi   Xu Guanhua   Xu Liqin   Cao Heng   Xu Bei   Chen Weiqian   Sun Chuanyin   Yue Lihuan   Lin Jin  

Oncology Letters, Vol. 11, Iss. 2, 2016-02 ,pp. : 1143-1145

Spandidos Publications

Access to resources Recommend Favorite

Phase I Study of Ofatumumab, a Human Anti-CD20 Antibody, in Japanese Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

By Ogura Michinori   Hatake Kiyohiko   Tobinai Kensei   Uchida Toshiki   Suzuki Tatsuya   Terui Yasuhito   Yokoyama Masahiro   Maruyama Dai   Mori Masakazu   Jewell Roxanne C.   Katsura Koichi   Hotta Tomomitsu  

Japanese Journal of Clinical Oncology, Vol. 43, Iss. 5, 2013-05 ,pp. : 466-475

Oxford University Press

Access to resources Recommend Favorite

The safety of bendamustine in patients with chronic lymphocytic leukemia or non-Hodgkin lymphoma and concomitant renal impairment: a retrospective electronic medical record database analysis

By Nordstrom Beth L.   Knopf Kevin B.   Teltsch Dana Y.   Engle Robert   Beygi Hooman   Sterchele James A.  

Leukemia and Lymphoma, Vol. 55, Iss. 6, 2014-06 ,pp. : 1266-1273

Informa Healthcare

Access to resources Recommend Favorite